Home > Momenta Pharmaceuticals Salary

Momenta Pharmaceuticals Salary

  • 24
  • 34
  • 11
Total 25 Momenta Pharmaceuticals Salaries. Sorted by Date, page 2
Ranked By:
Job Title Salaries City Year More info
Research Associate 50,000-60,000 Cambridge, MA, 02138 2012 Momenta Pharmaceuticals Research Associate Salaries (8)
Momenta Pharmaceuticals Cambridge, MA Salaries
Associate Scientist, Discovery 63,482-63,482 Cambridge, MA, 02138 2012 Momenta Pharmaceuticals Associate Scientist, Discovery Salaries (1)
Momenta Pharmaceuticals Cambridge, MA Salaries
Scientist, Nmr Spectroscopy 85,000-85,000 Cambridge, MA, 02138 2012 Momenta Pharmaceuticals Scientist, Nmr Spectroscopy Salaries (1)
Momenta Pharmaceuticals Cambridge, MA Salaries
Scientist, Translational Research 86,190-86,190 Cambridge, MA, 02138 2012 Momenta Pharmaceuticals Scientist, Translational Research Salaries (1)
Momenta Pharmaceuticals Cambridge, MA Salaries
Senior Scientist 120,000-120,000 Cambridge, MA, 02138 2012 Momenta Pharmaceuticals Senior Scientist Salaries (1)
Momenta Pharmaceuticals Cambridge, MA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Momenta Pharmaceuticals Jobs
See more Momenta Pharmaceuticals Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
1131

All Patents

192

Grant Patents

873

Patents Pending

325

Patents Families

More Recent
Momenta Pharmaceutical... Information
  • Momenta Pharmaceuticals, Inc.
  • Industry: BioTech/Drugs
  • City: Cambridge, MA
  • Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars (polysaccharides) for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. We are also utilizing our ability to sequence, or analyze the molecular structure of, sugars to create technology-enabled generic versions of complex sugar-based products. Our most advanced product candidate, M-Enoxaparin, is designed to be a technology-enabled generic version of Lovenox?, a widely prescribed low molecular weight heparin, or LMWH. Our novel product candidates include M118, a LMWH for the treatment